Levi & Korsinsky Reminds Nextracker Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 25, 2025 – NXT

NEW YORK, NY / ACCESS Newswire / January 27, 2025 / If you suffered a loss on your Nextracker Inc. (NASDAQ:NXT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/nextracker-inc-lawsuit-submission-form?prid=125447&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call […]

KYTX LAWSUIT ALERT: Levi & Korsinsky Notifies Kyverna Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline

NEW YORK, NY / ACCESS Newswire / January 27, 2025 / If you suffered a loss on your Kyverna Therapeutics, Inc. (NASDAQ:KYTX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/kyverna-therapeutics-inc-lawsuit-submission-form?prid=125446&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

Purpose Investments Files Preliminary Prospectus for the World’s First Solana ETF

TORONTO, Jan. 27, 2025 (GLOBE NEWSWIRE) — Purpose Investments Inc. (“Purpose”), the pioneer behind the world's first Bitcoin ETF and Ether ETF, is pleased to announce that it has filed a preliminary prospectus with Canadian securities regulators for the proposed launch of Purpose Solana ETF. The Purpose Solana ETF seeks to invest substantially all of

BlackRock(R) Canada Announces Final January Cash Distributions for the iShares(R) Premium Money Market ETF

(NYSE:BLK),(TSX:CMR), TORONTO, Jan. 27, 2025 (GLOBE NEWSWIRE) — BlackRock Asset Management Canada Limited (“BlackRock Canada”), an indirect, wholly-owned subsidiary of BlackRock, Inc. (NYSE: BLK), today announced the final January 2025 cash distributions for the iShares Premium Money Market ETF. Unitholders of record on January 28, 2025 will receive cash distributions payable on January 31, 2025.

Warning: Phishing Scam Impersonating the RCMP

The Royal Canadian Mounted Police (RCMP) and the Canadian Anti-Fraud Centre (CAFC) are warning the public about an ongoing phishing scam impersonating the RCMP. Unsolicited RCMP “delivery notices” are sent via text messages. The messages inform recipients that the RCMP was unable to deliver court documents and ask to reschedule to avoid missing a court

Investors who Lost Money on Micron Technology, Inc. (MU) Should Contact Levi & Korsinsky about Pending Class Action – MU

NEW YORK, NY / ACCESS Newswire / January 27, 2025 / If you suffered a loss on your Micron Technology, Inc. (NASDAQ:MU) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/micron-technology-inc-lawsuit-submission-form?prid=125453&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

Crocs, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before March 24, 2025 to Discuss Your Rights – CROX

NEW YORK, NY / ACCESS Newswire / January 27, 2025 / If you suffered a loss on your Crocs, Inc. (NASDAQ:CROX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/crocs-inc-lawsuit-submission-form?prid=125452&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call

Lost Money on Marqeta, Inc. (MQ)? Join Class Action Suit Seeking Recovery – Contact Levi & Korsinsky

NEW YORK, NY / ACCESS Newswire / January 27, 2025 / If you suffered a loss on your Marqeta, Inc. (NASDAQ:MQ) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/marqeta-inc-lawsuit-submission-form?prid=125451&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call

BriaCell Announces Completion of 15:1 Share Consolidation

(TSX:BCT),(NASDAQ:BCTXW),(NASDAQ:BCTX), PHILADELPHIA and VANCOUVER, British Columbia, Jan. 27, 2025 (GLOBE NEWSWIRE) — BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) (“BriaCell” or the “Company“), a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer care announces that on January 24, 2025 (the “Effective Date“), the Company completed a share consolidation (the “Consolidation“) of the

BriaCell Announces Completion of 15:1 Share Consolidation

BriaCell Announces Completion of 15:1 Share Consolidation GlobeNewswire January 27, 2025 PHILADELPHIA and VANCOUVER, British Columbia, Jan. 27, 2025 (GLOBE NEWSWIRE) — BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) (“BriaCell” or the “Company“), a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer care announces that on January 24, 2025 (the “Effective Date“),

Scroll to Top